Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,085 INR | -0.11% | +2.51% | +52.07% |
Sales 2024 * | 8.45B 101M 139M | Sales 2025 * | 10.78B 129M 177M | Capitalization | 55.18B 661M 905M |
---|---|---|---|---|---|
Net income 2024 * | 908M 10.88M 14.9M | Net income 2025 * | 1.42B 17.03M 23.33M | EV / Sales 2024 * | 6.41 x |
Net cash position 2024 * | 1.06B 12.65M 17.32M | Net cash position 2025 * | 1.2B 14.34M 19.64M | EV / Sales 2025 * | 5.01 x |
P/E ratio 2024 * |
60.3
x | P/E ratio 2025 * |
38.9
x | Employees | 838 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
1 day | -0.11% | ||
1 week | +2.51% | ||
Current month | +3.84% | ||
1 month | -2.16% | ||
3 months | +26.29% | ||
6 months | +134.28% | ||
Current year | +52.07% |
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Director of Finance/CFO | - | 20-06-28 | |
Kapil Dayya
CMP | Compliance Officer | - | 12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 20-03-30 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 20-03-30 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 1,085 | -0.11% | 1 365 |
24-04-29 | 1,086 | +0.16% | 7,930 |
24-04-26 | 1,085 | -0.75% | 7,964 |
24-04-25 | 1,093 | +2.85% | 3,421 |
24-04-24 | 1,063 | +0.37% | 8,112 |
Delayed Quote Bombay S.E., April 30, 2024 at 02:59 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- ORCHPHARMA Stock
- ORCHPHARMA Stock